J. Baker

发表

Safety of Daily Albuterol in Infants with a History of Bronchospasm: A Multi-Center Placebo Controlled Trial

W. Lincourt, J. Hedrick, R. Trivedi, 2009, The open respiratory medicine journal.

Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.

Wei Wu, C. Crim, R. Wasserman, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

J. Kemp, W. Busse, A. Emmett, 1999, Chest.

Daclizumab improves asthma control in patients with refractory asthma

W. Busse, E. Israel, H. Nelson, 2005 .

Preliminary safety and efficacy of daclizumab in the treatment of patients with moderate to severe chronic persistent asthma

W. Busse, P. Korenblat, R. Shames, 2004 .

Pathways Activated during Human Asthma Exacerbation as Revealed by Gene Expression Patterns in Blood

Geoffrey L. Chupp, Andrew A. Hill, Andrew J. Wardlaw, 2011, PloS one.

Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.

S. Szefler, P. Silkoff, M. Goldman, 2007, The Journal of allergy and clinical immunology.

Rhinovirus and influenza type A infections as precipitants of asthma.

C. Reed, E. Dick, J. Baker, 2015, The American review of respiratory disease.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

M. Goldberg, R. Wasserman, L. Mansfield, 2014, The journal of allergy and clinical immunology. In practice.

Office-based oral immunotherapy for food allergy is safe and effective.

R. Wasserman, L. Mansfield, R. Sugerman, 2011, The Journal of allergy and clinical immunology.

Safety features of budesonide inhalation suspension in the long-term treatment of asthma in young children

H. Eigen, J. Leflein, J. Baker, 2005, Advances in therapy.

Ciclesonide, a novel inhaled steroid, has no effect on hypothalamic-pituitary-adrenal (HPA)-axis function in mild-to-moderate asthmatics*

S. Rohatagi, C. Laforce, D. Banerji, 2003 .

Colonoscopic screening of asymptomatic patients with a family history of colon cancer

J. Ray, B. T. Ferrari, J. B. Gathright, 1990, Diseases of the colon and rectum.

Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study.

M. Schatz, R. Zeiger, J. Edelman, 2004, Respiratory medicine.

Colonoscopic Screening of Asymptomatic Family History of Colon Cancer Patients with a

J. Ray, J. B. Gathright, Ferrari, 2005 .

Increased leukocyte sensitivity to phosphodiesterase inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy.

J. Hanifin, S. Chan, J. Baker, 1984, The Journal of allergy and clinical immunology.

Elevated plasma antidiuretic hormone levels in status asthmaticus.

W. Segar, J. Baker, S. Yerger, 1976, Mayo Clinic proceedings.

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.

W. Busse, E. Israel, H. Nelson, 2008, American journal of respiratory and critical care medicine.

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.

R. Lockey, M. Riedl, B. Zuraw, 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Ogilvie's syndrome: Colonoscopic decompression and analysis of predisposing factors

J. Ray, J. B. Gathright, A. Timmcke, 1992, Diseases of the colon and rectum.

Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.

T. Craig, M. Riedl, A. Banerji, 2013, Allergy and asthma proceedings.

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

T. Machnig, J. Bernstein, W. Lumry, 2017, Allergy & rhinology.

Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.

M. Riedl, A. Reshef, A. Relan, 2017, The journal of allergy and clinical immunology. In practice.

Efficacy of Recombinant Human C1 Inhibitor Treatment for Abdominal Attacks of Hereditary Angioedema

S. Kivity, A. Reshef, D. Suez, 2012 .

Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.

J. Bernstein, M. Riedl, A. Relan, 2018, Allergy and asthma proceedings.

Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.

A. Reshef, H. Li, A. Relan, 2017, Allergy and asthma proceedings.

Cinryze™ Replacement Therapy in Hereditary Angioedema and Pregnancy

A. Sheffer, A. Banerji, J. Baker, 2009 .

Generalized lymphangiectasis associated with chylothorax; a possible dysplasia of the lymphatic system

J. Opitz, E. Gilbert, J. Herrmann, 2004, Zeitschrift für Kinderheilkunde.

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.

M. Kaliner, B. Lipworth, H. Kaiser, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings†

C. Reed, E. Dick, J. Baker, 1974, The Journal of Pediatrics.

Analgesia and anaesthesia in labour.

J. Baker, 1969, The Australian journal of physiotherapy.

ANTI‐C HAEMOLYTIC DISEASE REQUIRING INTRAUTERINE AND EXCHANGE TRANSFUSION

K. Harrison, J. Baker, P. Harvey, 1981, The Medical journal of Australia.

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.

M. Welch, K. Walton-Bowen, J. Baker, 1999, Pediatrics.

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS‐2 study

M. Triggiani, J. Bernstein, M. Gompels, 2018, Allergy.

Asthma control in pediatric patients treated with once-daily or twice-daily nebulized budesonide inhalation suspension (Pulmicort Respules).

P. Silkoff, T. Uryniak, J. Baker, 2008, Allergy and asthma proceedings.

Ogilvie's syndrome: Colonoscopic decompression and analysis of predisposing factors

J. Ray, A. Timmcke, J. Baker, 1992, Diseases of the colon and rectum.

Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.

S. Szefler, L. Carlsson, T. Uryniak, 2013, The journal of allergy and clinical immunology. In practice.